chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On the evening of 06/14/2022 I noticed a dry cough. The next morning, my wife urged me to go the medical center  because she stated that I was coughing all night. They gave me a PCR COVID-19 test which was negative. They also did a saliva COVID-19 test though and contacted me 4 hours later to inform me that I was positive and needed to isolate. I had already taken some over the counter Robitussin, in addition to that they gave me some Coricidin cold medication. On Friday, we were taken off the ship and transferred to a hotel. The following Wednesday, I tested positive again. On Friday 06/24/2022 I tested negative, and we were able to return home the following day. My symptoms improved over the course of that week and by the time I tested negative they were mostly gone except for some fatigue.
4/20 around 8:30am head started feeling heavy when running 4/20 around 11am, got very dizzy, nauseous, buzzing in ears 4/21 around 6pm, got very dizzy, nauseous, buzzing in ears 4/23 visited Primary Care Physican who referred me to Neurologist 4/29 saw neurologist 5/14 visited neurologist a second time Symptoms never went away
This case was reported by a other health professional via regulatory authority and described the occurrence of vaccination site pain in a adolescent male patient who received Men ACWY-CRM NVS (potential MENVEO)) for prophylaxis. Co-suspect products included GARDASIL for prophylaxis. On 20th April 2016, the patient received Meningococcal ACWY Vaccine (potential MENVEO) (intramuscular) and GARDASIL. On 21st April 2016, 1 days after receiving Meningococcal ACWY Vaccine (potential MENVEO), the patient experienced vaccination site pain (serious criteria hospitalization), feeling unwell (serious criteria hospitalization), unable to walk (serious criteria hospitalization), anorexia (serious criteria hospitalization), feeling bad (serious criteria hospitalization), facial flushing (serious criteria hospitalization), migraine aggravated (serious criteria hospitalization), faint (serious criteria hospitalization), weakness (serious criteria hospitalization), shortness of breath (serious criteria hospitalization), throat swelling (serious criteria hospitalization), rash (serious criteria hospitalization) and dizziness (serious criteria hospitalization). On 22nd April 2016, the outcome of the vaccination site pain, feeling unwell, unable to walk, anorexia, feeling bad, facial flushing, migraine aggravated, faint, weakness, shortness of breath, throat swelling, rash and dizziness were recovered/resolved. It was unknown if the reporter considered the vaccination site pain, feeling unwell, unable to walk, anorexia, feeling bad, facial flushing, migraine aggravated, faint, weakness, shortness of breath, throat swelling, rash and dizziness to be related to Meningococcal ACWY Vaccine (potential MENVEO). Additional details were provided as follows: The age at vaccination was not reported. On 20th April 2016, the patient received GARDASIL intramuscularly. It was unknown if the reporter considered the vaccination site pain, feeling unwell, unable to walk, anorexia, feeling bad, facial flushing, migraine aggravated, faint, weakness, shortness of breath, throat swelling, rash and dizziness to be related to GARDASIL as well. Correction done on 26 November 2018, following an internal QC. This case downloaded was incorrectly considered as received via the regulatory authority; this prevented report to FDA to auto schedule.
tested positive for covid-19/had rebound symptoms; the patient's partner gave COVID to him; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (tested positive for covid-19/had rebound symptoms) and EXPOSURE TO SARS-COV-2 (the patient's partner gave COVID to him) in an 80-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.    Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19 treatment.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form and NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. On 10-Nov-2022, the patient experienced COVID-19 (tested positive for covid-19/had rebound symptoms) and EXPOSURE TO SARS-COV-2 (the patient's partner gave COVID to him). On 02-Dec-2022, COVID-19 (tested positive for covid-19/had rebound symptoms) and EXPOSURE TO SARS-COV-2 (the patient's partner gave COVID to him) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Nov-2022, SARS-CoV-2 test: Positive. On 02-Dec-2022, SARS-CoV-2 test: Negative.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  The patient was fully vaccinated prior to developing COVID-19 infection. The patient's symptoms began on 10-Nov-2022. The patient complained about the metal taste and said that the coffee tasted awful. The patient received Paxiovid, had rebound symptoms of COVID-19, and finally tested negative on 02-Dec-2022.   This case was linked to US-MODERNATX, INC.-MOD-2022-672208 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-672208:same reporter (patient's partner case)
Entire body aches, pains, nausea, vomiting, roaring headaches, fever, exhaustion, bruising on injection sites.
Clinician spoke with patient by phone on 12/20/21 and patient reported the following: Started to experience pain in left arm on 12/17 after getting the vaccines done. On Saturday started to get pain in left axillary area and redness  in skin overlying axilla. Having pain that comes and goes in that area over last 2 days that is severe enough that hasn't been able to work. No weakness in fingers. Able to move hand normally. No fever. Used ibuprofen 400 mg yesterday am with some improvement. Reviewed 2 pictures patient sent to mobile phone showing mild pink erythema overlying left axilla.  Appears that having reaction with some lymphadenopathy and some soft tissue swelling and skin erythema, all of which have been reported as potential of side effects of flu vaccine or Tdap vaccine.  Local swelling can also happen with pneumovax.  Advised patient to use ibuprofen OTC up to 800 mg every 8 hours for next few days.   Call if symptoms don't improve over next 3-4 days. Call if any loss of strength or function in hand or fingers  Pt had unrelated appointment 12/23/21 and no mention is made about continued s/s from injection reaction.
Pt brought to med obs #1 via stretcher for c/o dizziness, generalized tingling, diaphoresis, tunnel vision and brief LOC prior to stretcher arrival. Pt reports he "came to" almost immediately after experiencing tunnel vision and refused to lie on floor with BLE elevated prior to stretcher arrival. Pt ambulatory without difficulty. Accepted water, declined snack, states he ate breakfast PTA. VSS. No s/s of distress noted. S/O at bedside. Escorted to exit with staff. VS are as follows: 1140: BP 166/99, HR 100, RR 20, O2 sat 98% on RA 1145: BP 149/98, HR 91, RR 18, O2 sat 98% on RA
It seemed that the adverse reaction began about 48 hours after the injection. Side effects included: severe vascular pain throughout both legs (predominantly the left leg), and intermittent "pin" and needle type stinging throughout the vascular pain. This lasted for about three days and effected my ability to walk and caused lots of emotional and physical stress.
Got shingles two weeks after the shot; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 2 weeks after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient was reporter's mother best friend. The age at vaccination was not reported. The reporter stated that two weeks after the patient got the Shingles shot, she got shingles. The reporter stated that it was horrible for him/her because he/she was in his/her 70's. The reporter stated that this was not a good idea. The follow up would not be possible as no contact details were available. This case had been linked with case US2021AMR195351, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR195351:Same reporter.
This spontaneous report was received from a medical assistant refers to a patient of unknown age who on 08-AUG-2014 the patient was vaccinated with an improperly stored dose of ((Oka/Merck) PROQUAD (lot#, expiration date and dose unspecified). No adverse events were reported. No further information was provided. This is one of several reports received from the same source. Additional information has been requested.
Heart attack symptoms - chest pain, shortness of breath, pounding heart approx. 1 week after 1st shot.  Hospitalized with small heart attack.  After 2nd shot, emergency room visit for stroke-related symptoms - numbness in left side of face and left arm.  Test results did not reveal cause.  2 months later still experiencing chest pain in and around heart.  No prior health issues or heart related issues other than high blood pressure and cholesterol.
severe stomach pains; bad headache; dizzy; Didn't have any energy and strength; Cold sweats; Nauseous; This is a spontaneous report from a contactable consumer (patient). A 56-year-old female patient not pregnant received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the Left arm on 20Jan2021 at 02:45 PM as a single dose for COVID-19 immunisation, lot number: EL3247. Medical history included chronic lyme disease. Concomitant medications were not provided. Patient had no allergies to medications, food, or other products. Prior to vaccination the patient was not diagnosed with COVID-19. Patient did not receive other vaccine in four weeks prior to the COVID vaccine. On 23Jan2021 at 12:00 AM patient had severe stomach pains with a bad headache. Shortly after she got dizzy, did not have any energy and strength. She had cold sweats. Patient tried sips of water, but it made her nauseous. This all happened all at once and it hit patient hard in the middle of her work. No treatment received for the events. Since the vaccination patient had not been tested for COVID-19. Patient was recovering from the events.
patient came in office to obtain the COVID19 (Pfizer-BioNTech Bivalent dose. patient was given the Monovalent dose by error. Patient was let known of what was given and patient stated she had no symptoms but would still like to obtain the Bivalent dose after time frame period. This is patient 4 dose of the Monovalent and per Dr. Patient is able to continue with no further directions .
I am 70 yrs. old and healthy. I had the strong dose flu shot. Until this shot, I have not had a reaction to the flu shot. Sept. 23 - core ached. Sept. 24 - feverish, strong headache. Sept. 25 - feverish, headache, fever blisters - 3 mouth. Sept. 24-29th - continual headache. First time for strong dose. Concern  - may not get this shot again; affect to others.
Information has been received from a consumer concerning her son with penicillin allergy who was vaccinated in January 2005, with MMR II (Merck) (route and dose unknown). The mother reported that her son, in January -2005 developed fever of 103F lasting several days and rash characterized by small bumps all over his body. The patient was treated with MOTRIN. The outcome of the patient recovered (date unknown). The patient sought medical attention by a phone call to the physician's office. Additional information has been requested.
Fever, chills, headache, fatigue, body aches/muscle soreness. I understand these were expected and not dangerous to me.   Symptoms started very mild but were more intense as time passed, the worst flue-like symptoms were approximately 20 hours after my second shot. I went to bed that night  my fever broke sometime that night,  approximately 28-30 hours after my second shot. Happy to say I felt completely normal the next day.
Vertigo 45 minutes after the shot, dizziness and panic attack the next day, chest pain for two days afterwards, lump on my throat on right side, extreme fatigue and brain fog, all of these side effects started getting better after 7 weeks. I am waiting on biopsy results from cyst is right neck lymph node
Pt was given Moderna COVID19 Vaccine 01/14/2021 (1st dose) 2nd dose Moderna COVID19 Vaccine given 02/04/2021 (21 days instead of 28 days after 1st dose)
Slight headache, body aches, fatigue, chills.  I felt OK the next morning.
The first week of January I had fever and I felt really tired I couldn't think clearly my left felt like it was not clear neither. It was clocked up. It also started hurting a bit. I did go to see a doctor about my ear issue he said it will clear by itself. The next day I went to get a COVID test and it came up positive. I had to quarantine for 10 days, After I felt much better.
Information has been received from a physician concerning a 3 year old male who in approximately 2005, at "12 months of age", was vaccinated with a dose of Varivax. Subsequently the patient experienced breakthrough chicken pox. Unspecified medical attention was sought and the patient recovered. It was noted that the physician was not sure if she will give a booster dose. Additional information has been requested.
patient reported right upper arm swelling, redness, pain and heat. she stated she did not take benadryl until the evening of 9/13 and it had improved by the morning of the 14th.
Per Safety RN to this writer: Pt here for 2nd dose of Pfizer vaccine c/o dizziness and lightheaded. Pt is alert and oriented and able to articulate at baseline. Aid called to evaluate Pt. Pt given water and reported to aid he no longer felt dizzy. Pt asked to stand up by medics and Pt reported " I no longer feel dizzy." Pt cleared to drive home safely by Medics.  VS 1125 per Medics  BP 110/70 HR 66 O2 sat 100% on RA  VS 1129 per Medics BP 108/60 HR 66 O2 sat 100% on RA
Vaccine administered to a 21month baby boy; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 1-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 2G3PH, expiry date 27th October 2023) for prophylaxis.   On 17th June 2022, the patient received Boostrix. On 17th June 2022, unknown after receiving Boostrix, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   Additional Information: GSK Receipt Date: 17-Jun-2022 Reporter's comments: Medical Assistant administered a Boostrix to 21 months old patient. The consent to follow up was given by mail. Additional Supportive Information: Twenty one months old patient received Boostrix, which led to inappropriate age at vaccine administration.
Started having chills and a fever. Took a home COVID-19 test and was positive. Contacted doctor and prescribed molnupiravir.
This spontaneous report as received from a physician concerning a 78 year old female patient with sulfonamide allergy who on an unknown date in 2011 was vaccinated with a 0.65ml dose of ZOSTAVAX, subcutaneous (lot number not provided). The physician started that on an unknown date approximately three months later after ZOSTAVAX vaccination (no dates provided) the patient developed a severe case of shingles. The unspecified patient experienced severe post herpetic neuralgia as well as classic shingles symptoms according to the physician. The outcome of severe case of shingles was reported as fully recovered. Additional information has been requested.
Patient presented to office with itchy rash on stomach, arms, legs and back x 4 days. No fever. Rash was diagnosed by PCP, as Varicella.
1:45 right arm immediate reddened area 4" x 2" for 1 1/2 hours. Parent called. Physician called. Ice to arm. 3 PM Benadryl 150mg po given. Reddened area decreased.
2 MINUTES POST VACCINATION PT BECAME SWEATY, ANXIOUS, DIZZY AND DEVELOPED TUNNEL VISION. PT TRANSPORTED TO OBS VIA WC. VSS. HUSBAND AT BEDSIDE. PT SLOWLY TRANSITIONED FROM LYING, TO SITTING AND THEN STANDING. ALL SYMPTOMS RESOLVED. PT RELEASED AT 1700. PT AND HUSBAND ESCORTED TO EXIT WITH NO FURTHER ISSUES. VITALS AS FOLLOWS: 1643 BP 138/85 HR 68 RR 20 SPO2 99 1649 BP 138/87 HR 77 RR 20 SPO2 100 1656 SITTING BP 133/88 HR 78 SPO2 98 1659 STANDING BP 130/66 HR 100 SPO2 98
Sore throat for over a week,  moderate headache, pain at the injection site for 3 days, congestion, thick green/bloody phlegm, nighttime coughing, fatigue for over a week, restlessness.
A report has been received from a Health Professional concerning a 3 year old, Male subject, who had been receiving FLUMIST, (intranasal). FLUMIST started on 16-Aug-2013. The reporter stated that the patient had received flu shot and FLUMIST by mistake/child received flu shot on Oct 8th and FLUMIST on Oct 16th by mistake is unknown. The report was considered to be non-serious.
Mom noticed a little swelling about 2 hours after the vaccine. The swelling noted to be significantly increased yesterday. Swelling from groin to just below knee cap. No redness, No c/o pain. Pt walking on his toes, left leg only, yesterday which he never does.
7 days after my 2nd shot, I started experiencing tingling in the feet which progressed to my hands until on May 11th, I couldn't walk on my own and my husband took me to Emergency at Medical Center. They transferred me to other Medical Center that same day where I had multiple blood tests, MRIs, CT scans, lumbar puncture. I spent 8 days there and was transferred to Rehab Facility for 3 weeks. They are pretty sure it is GBS. I am in a wheelchair and have started to use a walker. My fine motor skills are diminished- difficult to type, hold small objects, etc.
Early menstruation. My period usually comes on regular cycle of 29-30 days. I got my period at 24 days (6 days after receiving booster). I have never had an early period in my life. It was extremely painful and heavy flow.
Left Arm hurts a Little,; Left Arm hurts a Little, Stomach Ache, Nausea, Diarrhea; Left Arm hurts a Little, Stomach Ache, Nausea, Diarrhea; Nausea,; A spontaneous report was received from a consumer  concerning an 80 year old female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and developed a stomach ache/abdominal pain upper, her left arm hurt/pain in extremity, nausea, and diarrhea.  The patient's medical history included Crohn's disease.  No relevant concomitant medications were reported.   On 22 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot number 032L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   The patient's arm hurt after receiving the vaccine on 22 Jan 2021.  She also experienced a stomach ache, nausea, and diarrhea for nine days.  She treated the events with meclizine.  Action taken with mRNA-1273 in response to the events was not provided.   The outcome of the events stomach ache, nausea, and diarrhea were not reported.  The outcome of the event arm pain was recovered/resolved on 25 Jan 2021.  Reporter causality for the events was not provided.; Sender's Comments: Based on the current available information which shows a temporal association between the use of mRNA-1273 and the onset of the events, a causal relationship cannot be excluded. Nausea is consistent with the known safety profile of mRNA-1273.
The next evening I began noticing a cloudiness in my Right Eye vision.  Additionally, there were moving swirls of lights.  This was not the same as an ocular migraine.  The lights eventually went away a week or so later but the cloudiness remained.
Fatigue 6 hours after, fever, chills and body aches 16 hours after - continued into the next day.
Had a little bump right after injection 3 weeks later had a 4 inch lump under the skin with 7 inches of redness around area. Left arm pain, shoulder, and neck pain.
This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), MENSTRUAL DISORDER (Menstrual period), VERTIGO (Extreme vertigo where she couldn't walk), NAUSEA (Nausea) and FATIGUE (Feeling a little soggy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical conditions reported.). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced HEADACHE (Headache). On 21-Jan-2021, the patient experienced MENSTRUAL DISORDER (Menstrual period). On an unknown date, the patient experienced VERTIGO (Extreme vertigo where she couldn't walk), NAUSEA (Nausea) and FATIGUE (Feeling a little soggy). At the time of the report, HEADACHE (Headache), MENSTRUAL DISORDER (Menstrual period), VERTIGO (Extreme vertigo where she couldn't walk), NAUSEA (Nausea) and FATIGUE (Feeling a little soggy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment included,Augmentin antivertigo medication and an antinausea medication.
Developed a wheal and flare reaction approx. 1 inch in diameter with associated induration and itchiness at the site of the injection. Noticed it the day after the reaction.
I felt sick, like bad cold; My right arm was red; My right arm was swollen; This spontaneous case was reported by a patient and describes the occurrence of ERYTHEMA (My right arm was red), PERIPHERAL SWELLING (My right arm was swollen) and NASOPHARYNGITIS (I felt sick, like bad cold) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced ERYTHEMA (My right arm was red) and PERIPHERAL SWELLING (My right arm was swollen). On 08-Mar-2021, the patient experienced NASOPHARYNGITIS (I felt sick, like bad cold). In March 2021, NASOPHARYNGITIS (I felt sick, like bad cold) had resolved. At the time of the report, ERYTHEMA (My right arm was red) and PERIPHERAL SWELLING (My right arm was swollen) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No Concomitant medications were provided.  It was reported that after receiving first dose of Moderna Covid-19 vaccine patient felt sick, like bad cold for about 5 days.  No treatment medications were provided.   This case was linked to MOD-2022-664780, MOD-2021-093399 (Patient Link).
PT WAS AT CHCKOUT. PT LEANED OVER GRASPING HIS CHEST. PT PLACED INTO OBSERVATION CHAIR AND IMMEDIATELY BROUGHT TO OBSERVATION ROOM WHERE HE WAS ASSESED BY STAFF NURSES, MEDICAL PROVIDER, EMT'S. . PT MASK REMOVED UPPER LUP SWOLLEN. AIRWAY PATENT, NO S/S OF RESPIRATORY DISTRESS NOTED. PT GRASPING CHEST, MOANING IN PAIN. 12 LEAD EKG PERFORMED SINUS TACH. 18 GUAGE SL PLACED TO RT HAND, ATTEMPT X 1 PT TOLERATED WELL.  BENADRYL 50MG IM X 1 DETHAMEXASONE 10MG IMX 1 CHEWABLE ASPIRIN 324MG PO X1 12:45 PT HR TACHY AT 132, RR20,  B/P136/82 12:49 PT HR 125, RR20, B/P 138/88 12:54 PT HR 119, RR 19, BP 159/83 1300: RESCUE ARRIVED, CARE TAKEN OVER FROM THERE.  PT REMAINS STATUS REMAINS FAIR AND STABLE UPN D/C